BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28189165)

  • 1. The Big 3: An Updated Overview of Colorectal, Breast, and Prostate Cancers.
    Gordon J; Fischer-Cartlidge E; Barton-Burke M
    Nurs Clin North Am; 2017 Mar; 52(1):27-52. PubMed ID: 28189165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four major cancers that affect South Dakotans and the U.S. population: breast, colorectal, lung and prostate.
    Vogt HB; Hansen K
    S D Med; 2010; Spec No():5. PubMed ID: 20401982
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study.
    Lewis MA; Zhao F; Jones D; Loprinzi CL; Brell J; Weiss M; Fisch MJ
    J Pain Symptom Manage; 2015 Jun; 49(6):1016-24. PubMed ID: 25596011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Disparities Vary by Patient Life Expectancy in Screening for Breast, Prostate, and Colorectal Cancers.
    Schoenborn NL; Huang J; Boyd CM; Pollack CE
    J Gen Intern Med; 2020 Nov; 35(11):3389-3391. PubMed ID: 31797159
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study.
    McDavid K; Schymura MJ; Armstrong L; Santilli L; Schmidt B; Byers T; Steele CB; O'Connor L; Schlag NC; Roshala W; Darcy D; Matanoski G; Shen T; Bolick-Aldrich S;
    Cancer Causes Control; 2004 Dec; 15(10):1057-66. PubMed ID: 15801489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study.
    Khan NF; Mant D; Carpenter L; Forman D; Rose PW
    Br J Cancer; 2011 Nov; 105 Suppl 1(Suppl 1):S29-37. PubMed ID: 22048030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
    Dahlhaus A; Semlitsch T; Jeitler K; Horvath K; Siebenhofer A
    Fam Pract; 2015 Oct; 32(5):483-91. PubMed ID: 26142418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic blockers and the risk for common solid cancers: a case-control study.
    Numbere B; Fleming KM; Walker A; Card TR
    Eur J Cancer Prev; 2017 Jan; 26(1):86-93. PubMed ID: 26649549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise in cancer survivors: an overview of research.
    Courneya KS
    Med Sci Sports Exerc; 2003 Nov; 35(11):1846-52. PubMed ID: 14600549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer in Canada: Stage at diagnosis.
    Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
    Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of the four major cancers in South Dakota.
    Clarke J
    S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
    Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence trends differ between Europe, United States.
    Miller M
    J Natl Cancer Inst; 2001 Oct; 93(19):1444-5. PubMed ID: 11584056
    [No Abstract]   [Full Text] [Related]  

  • 16. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
    Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
    Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and cancer: what is the connection?
    Cannata D; Fierz Y; Vijayakumar A; LeRoith D
    Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.